Skip to content
mephenytoin

Structure via PubChem · Public domain (PubChem)

EntityQ1175385· pop 10· linked from 403 articles

mephenytoin

Sign in to save

Also known as MES204, Mesantoin®

Mephenytoin (marketed as Mesantoin by Novartis) is a hydantoin, used as an anticonvulsant. It was introduced approximately 10 years after phenytoin, in the late 1940s. The significant metabolite of mephenytoin is nirvanol (5-ethyl-5-phenylhydantoin), which was the first hydantoin (briefly used as a hypnotic). However, nirvanol is quite toxic and mephenytoin was only considered after other less toxic anticonvulsants had failed. It can cause potentially fatal blood dyscrasia in 1% of patients.

Chemical data

Formula
C12H14N2O2
Molecular weight
218.25 g/mol
IUPAC name
5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione
SMILES
CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2
InChIKey
GMHKMTDVRCWUDX-UHFFFAOYSA-N
XLogP
1.5
Polar surface area
49.4 Ų
H-bond donors
1
H-bond acceptors
2
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1946
Admin. routes
oral
Indications
epilepsy

via ChEMBL · EBI

Research

1,086 papers

via PubMed

Wikidata facts

Mass
218.106
Has use
medication
Show 6 more facts
chemical formula
C₁₂H₁₄N₂O₂
medical condition treated
temporal lobe epilepsy
canonical SMILES
CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2
defined daily dose
0.4
subject has role
anticonvulsant agent
Commons category
Mephenytoin
Sources (6)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Mephenytoin (marketed as Mesantoin by Novartis) is a hydantoin, used as an anticonvulsant. It was introduced approximately 10 years after phenytoin, in the late 1940s. The significant metabolite of mephenytoin is nirvanol (5-ethyl-5-phenylhydantoin), which was the first hydantoin (briefly used as a hypnotic). However, nirvanol is quite toxic and mephenytoin was only considered after other less toxic anticonvulsants had failed. It can cause potentially fatal blood dyscrasia in 1% of patients.

Mephenytoin is no longer available in the US or the UK. It is still studied largely because of its interesting hydroxylation polymorphism.

Excerpted from Wikipedia’s “mephenytoin” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0